Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017.
Where this comes from
- Record sourced from PubMed, PMID 31566649.
- Also identified by DOI 10.1001/jamainternmed.2019.3884 and PMC identifier 6777260.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines trends in aggregate use and expenditures for diabetes mellitus therapies among US Medicare Part D beneficiaries.
Medical subject headings
- Health Expenditures
- Hypoglycemic Agents
- Medicare